The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

• Status: Completed
• Trial end date: 1996-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will investigate the additive effect of montelukast (MK0476) taken along with inhaled beclomethasone versus inhaled beclomethasone alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Beclomethasone; Montelukast

Criteria

Inclusion Criteria:

• Female patients tested negative for pregnancy and agreed to use appropriate contraceptives through out the study

• Patient was a nonsmoker

• Patient was in good general health (except for asthma)

Exclusion Criteria:

• Patient was hospitalized

• Patient was female who was less than 8 weeks postpartum or breast feeding

• Patient planned to move or vacation away during the study

• Patient had major surgery within 4 weeks the past 4 weeks

• Patient has donated blood or participated in a clinical trial within the past 4 weeks

• Patient was a regular user or recent abuser of alcohol or illicit drugs

• Patient was 40% over or under normal weight for height